Factor Xa inhibitors: all 607 studies that test it
Page 3 of 7. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity ArthroplastyCompletedNCT01809054Phase 4Results posted
- Edoxaban in Peripheral Arterial DiseaseCompletedNCT01802775Phase 2Results posted
- AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) PatientsCompletedNCT01780987Phase 3Results posted
- Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery DiseaseCompletedNCT01776424Phase 3Results posted
- A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation TherapyCompletedNCT01729871Phase 3Results posted
- Oral Rivaroxaban in Children With Venous ThrombosisCompletedNCT01684423Phase 2Results posted
- Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for CardioversionCompletedNCT01674647Phase 3Results posted
- A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein ThrombosisCompletedNCT01662908Phase 2Results posted
- Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee ArthroscopyCompletedNCT01629381Phase 2Results posted
- Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)CompletedNCT01583218Phase 3Results posted
- Switching Study From Warfarin to RivaroxabanCompletedNCT01507051Phase 1Results posted
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus FondaparinuxCompletedNCT01499953Phase 3Results posted
- Fondaparinux in Critically Ill Patients With Renal FailureCompletedNCT01467583Phase 4Results posted
- Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet RivaroxabanCompletedNCT01436526Phase 1Results posted
- Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on HemodialysisCompletedNCT01340586Phase 1Results posted
- Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial FlutterCompletedNCT01229254Phase 2Results posted
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
- A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01181167Phase 3Results posted
- Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedNCT01181141Phase 3Results posted
- A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
- Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee ReplacementCompletedNCT01094886Phase 3Results posted
- A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal ImpairmentCompletedNCT00999336Phase 1Results posted
- Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
- The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00981409Phase 3Results posted
- Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart RhythmCompletedNCT00911300Phase 2Results posted
- The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00911157Phase 3Results posted
- The Effects of Arixtra on Wound Drainage Following Total Joint ArthroplastyCompletedNCT00909064Phase 4Results posted
- A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese PatientsTerminatedNCT00852397Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing SurgeryCompletedNCT00843492Phase 3Results posted
- Phase III Acute Coronary SyndromeTerminatedNCT00831441Phase 3Results posted
- Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial FibrillationCompletedNCT00829933Phase 2Results posted
- An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary SyndromeCompletedNCT00809965Phase 3Results posted
- DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial FibrillationCompletedNCT00806624Phase 2Results posted
- A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNCT00789399Not applicableResults posted
- A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial FibrillationCompletedNCT00787150Phase 2Results posted
- Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 InducerCompletedNCT00786422Phase 2Results posted
- Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial FibrillationCompletedNCT00781391Phase 3Results posted
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to WarfarinCompletedNCT00742859Phase 2Results posted
- Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)TerminatedNCT00673439Phase 2Results posted
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00643201Phase 3Results posted
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00633893Phase 3Results posted
- Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00571649Phase 3Results posted
- Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.CompletedNCT00555438Phase 4Results posted
- Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic MalignancyTerminatedNCT00539942Phase 3Results posted
- The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma PatientsCompletedNCT00531843Phase 2/3Results posted
- Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNCT00521885Not applicableResults posted
- A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial FibrillationCompletedNCT00504556Phase 2Results posted
- A Phase III Study of Apixaban in Patients With Atrial FibrillationCompletedNCT00496769Phase 3Results posted
- Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial FibrillationCompletedNCT00494871Phase 3Results posted
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical IllnessCompletedNCT00457002Phase 3Results posted
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryCompletedNCT00452530Phase 3Results posted
- Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT StudyCompletedNCT00440193Phase 3Results posted
- Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE StudyCompletedNCT00439777Phase 3Results posted
- Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension StudyCompletedNCT00439725Phase 3Results posted
- Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous ThromboembolismTerminatedNCT00423683Phase 3Results posted
- Apixaban for the Prevention of Stroke in Subjects With Atrial FibrillationCompletedNCT00412984Phase 3Results posted
- Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With ThrombosisCompletedNCT00412464Phase 1Results posted
- An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationCompletedNCT00403767Phase 3Results posted
- Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)CompletedNCT00402597Phase 2Results posted
- A Study of DU-176b in Preventing Blood Clots After Hip Replacement SurgeryCompletedNCT00398216Phase 2Results posted
- Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedNCT00381888Phase 2Results posted
- Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)CompletedNCT00375609Phase 2Results posted
- Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00362232Phase 3Results posted
- Hip Fracture Study of GSK576428 (Fondaparinux Sodium)CompletedNCT00320424Phase 3Results posted
- Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)CompletedNCT00320398Phase 3Results posted
- Safety Study of Apixaban in Recent Acute Coronary SyndromeCompletedNCT00313300Phase 2Results posted
- Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip ReplacementCompletedNCT00107900Phase 2Results posted
- Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet Therapy (Aspirin and Clopidogrel)Active, not recruitingNCT07853612Phase 4
- Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed ConditionsCompletedNCT07807488Phase 1
- Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary EmbolismCompletedNCT07774273Not applicable
- Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser AblationCompletedNCT07699796Phase 4
- Rivaroxaban in Pediatric Patients With DVTCompletedNCT07618988Phase 4
- Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous ThrombosisCompletedNCT07523347Not applicable
- A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy ParticipantsCompletedNCT07312851Phase 1
- A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of EdoxabanActive, not recruitingNCT07113054Phase 1
- COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSISCompletedNCT07077954Phase 1
- Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular DiseasesCompletedNCT06986369Phase 4
- Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet DrugsCompletedNCT06933056Early Phase 1
- Bioequivalence Study of Apixaban 5 mg Film-Coated TabletCompletedNCT06817811Phase 1
- Bioequivalence Study of Rivaroxaban 10 mg Film-coated TabletsCompletedNCT06558058Phase 1
- Bioequivalence Study of Rivaroxaban 20 mg Film-coated TabletsCompletedNCT06558045Phase 1
- Dabigatran Versus Apixaban in Cerebral Venous ThrombosisStatus unknownNCT06551415Phase 3
- The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNCT06449469Not applicable
- Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral AnticoagulantCompletedNCT06372483Phase 1
- Rivaroxaban Sotorasib Interaction StudyCompletedNCT06314763Phase 4
- Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human SubjectsCompletedNCT06043297Phase 1
- Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy VolunteersCompletedNCT05995119Early Phase 1
- Perioperative Management of Factor Xa InhibitorsCompletedNCT05801068Not applicable
- Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque InflammationCompletedNCT05797376Phase 4
- Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon AngioplastyCompletedNCT05750758Not applicable
- PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy VolunteersCompletedNCT05723510Phase 1
- Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMICompletedNCT05705089Phase 3
- Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage OcclusionStatus unknownNCT05671276Phase 4
- To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary SyndromeStatus unknownNCT05573958Phase 4
- Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen OvaleCompletedNCT05546320Phase 2
- Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic EventsCompletedNCT05515120Phase 2/3
- Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants SubjectsStatus unknownNCT05491460Phase 1
- Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial FibrillationCompletedNCT05320627Phase 4
- Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular RevascularizationStatus unknownNCT05308030Early Phase 1